Overview

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Status:
Recruiting

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

This study aim to investigate Changes in tumor tissue and serum biomarkers before and after cetuximab combined with preoperative radiotherapy in locally advanced thoracic middle-lower segment esophageal squamous cell carcinoma.We want to find one or more effective biomarkers to predict and evaluate the patients who will be benefit from cetuximab combined with preoperative radiotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Sichuan Cancer Hospital and Research Institute

Collaborators:

Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Tumor Hospital of Guangzhou Medical University
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Southwest Hospital, China
Xinqiao Hospital of Chongqing

Treatments:

Cetuximab